Possible prediction of adverse reactions to pyrimidine chemotherapy from urinary pyrimidine levels and a case of asymptomatic adult dihydropyrimidinuria

Clinical Cancer Research

Volumn 2, Issue 12, 1996, Pages 1937-1941

  Hayashi, Katsuo ^a   Kidouchi, Kiyoshi ^a   Sumi, Satoshi ^b   Mizokami, Masashi ^b   Orito, Etsuro ^b   Kumada, Kazunori ^a   Ueda, Ryuzo ^b   Wada, Yoshiro ^b  

^a Nagoya City Higashi General Hospital   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROURACIL; FLUOROURACIL; PYRIMIDINE DERIVATIVE; URACIL;

ABNORMAL URINE COMPOSITION; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PYRIMIDINE METABOLISM; URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; URACIL;

EID: 0030469777     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Perignon, J. L., Bories, D. M., and Houllier, A. M. Metabolism of pyrimidine bases and nucleosides by pyrimidine-nucleoside phosphorylases in: cultured cells. Biochim. Acta, 928: 130, 1987.
2. Diasio, R. B., Beavers, T. L., and Carpenter, J. T. Familial deficiency of dihydropyrimidine dehydrogenase: biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity. J. Clin. Invest., 81: 47-51, 1988.
3. Harris, B. E., Carpenter, J. T., and Diasio, R B 5-Fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. Cancer (Phila.), 68: 499-501, 1991.
4. Lu, Z., Zhang, R., and Diasio, R. B. Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients and clinical implication in 5-fluorouracil chemotherapy. Cancer Res., 53: 5433-5438, 1993.
5. Milano, G., and Etienne, M. C. Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapy. Pharmacogenetics, 4: 301-306, 1994.
6. Henderson, M. J , Ward, K., Simmonds, H. A., Duley, J, A., and Davies, P. M. Dihydropyrimidinase deficiency presenting in infancy with severe developmental delay. J. Inherited Metab. Dis., 16: 574-576, 1993.
7. Ohba, S., Kidouchi, K., Sumi, S., Imaeda, M., Takeda, N., Yoshizumi, H., Tatematsu, A., Kodama, K., Yamanaka, K., Kobayashi, M., and Wada, Y. Dihydropyrimidinuria: the first case in Japan. Adv. Exp. Med. Biol., 370: 383-386, 1995.
8. Ohba, S., Kidouchi, K, Katoh, T., Kobayashi, M., and Wada, Y. Automated determination of orotic acid, uracil and pseudouridine in urine by high-performance liquid chromatography with column switching. J. Chromatogr., 568: 325-332, 1991.
9. Kidouchi, K., Nakamura, C., Katoh, T., Ohba, S., and Wada, Y. Automated quantitative analysis for orotidine and uridine/thymine in urine by high-performance liquid chromatography with column switching. Adv. Exp. Med. Biol., 309B: 31-34, 1991.
10. Sumi, S., Kidouchi, K., Ohba, S., and Wada, Y. Automated screening system for purine pyrimidine metabolism disorders using high-performance liquid chromatography. J. Chromatogr. Biomed., 672: 233-239, 1995.
11. Duran, M., Rovers, P., de Bree, P. K., Schreuder, C. H., Beukenhorst, H , Dorland, L., and Berger, R. Dihydropyrimidinuria: a new inborn error of pyrimidine metabolism. J. Inherited Metab. Dis., 14: 367-370, 1991.